Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

101.53
Delayed Data
As of Feb 27
 -2.86 / -2.74%
Today’s Change
47.03
Today|||52-Week Range
111.49
+4.67%
Year-to-Date

Today’s Trading

Previous close104.39
Today’s open104.80
Day’s range100.03 - 105.48
Volume574,929
Average volume (3 months)715,330
Market cap$8.5B
Dividend yield--
Data as of 4:00pm ET, 02/27/2015

Growth & Valuation

Earnings growth (last year)-234.48%
Earnings growth (this year)+37.33%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+7.20%
P/E ratioNM
Price/Sales142.50
Price/Book8.37

Competitors

 Today’s
change
Today’s
% change
ISISIsis Pharmaceuticals...+1.23+1.83%
QQuintiles Transnatio...+0.03+0.05%
ICLRICON PLC-0.43-0.62%
CRLCharles River Labora...-0.10-0.13%
Data as of 4:14pm ET, 02/27/2015

Financials

Next reporting dateMay 4, 2015
EPS forecast (this quarter)-$0.68
Annual revenue (last year)$50.6M
Annual profit (last year)-$360.4M
Net profit margin-712.79%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John M. Maraganore
President &
Chief Operating Officer
Barry E. Greene
Corporate headquarters
Cambridge, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account